Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: Analysis of 155 donor-recipient pairs

Hideya Kamei, Satohiro Masuda, Taro Nakamura, Masatoshi Ishigami, Yasuhiro Fujimoto, Yasuhiro Ogura, Fumitaka Oike, Yasutsugu Takada, Nobuyuki Hamajima

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Despite improvements in immunosuppressive therapy, acute cellular rejection (ACR) remains an important cause of graft loss in patients undergoing liver transplantation. Recently, associations between cytokine gene polymorphisms in recipients and the occurrence of ACR have been reported. However, most studies did not investigate gene polymorphisms in donors or were limited by the number of cases investigated. Methods: We examined 155 living donor liver transplantation (LDLT) patients treated at Nagoya University or Kyoto University from 2004 to 2009. The following gene polymorphisms in recipients and donors were analyzed: tumor necrosis factor A (TNF-A) T-1031C, interleukin 2 (IL-2) T-330G, IL-10C-819T, IL-13C-1111T, and transforming growth factor B (TGF-B) T29C. Results: Forty-seven recipients (30.3 %) developed early ACR. Of the investigated gene polymorphisms, the IL-13 -1111C/C genotype in recipients was significantly associated with a higher incidence of ACR relative to the other two genotypes (OR = 2.64, 95 % CI 1.19-5.86, p = 0.017), while we showed the lack of association between investigated gene polymorphisms in donors and ACR incidence. Conclusion: The IL-13 -1111C/C genotype in recipients might be a risk factor for ACR in LDLT, and this might contribute to individualized immunosuppression strategies for recipients. On the other hand, the current study showed no associations of cytokine gene polymorphisms in donors with ACR incidence.

Original languageEnglish
Pages (from-to)916-922
Number of pages7
JournalHepatology International
Volume7
Issue number3
DOIs
Publication statusPublished - Jul 1 2013
Externally publishedYes

Fingerprint

Living Donors
Liver Transplantation
Tissue Donors
Cytokines
Genes
Interleukin-13
Genotype
Incidence
Transforming Growth Factors
Immunosuppressive Agents
Immunosuppression
Interleukin-2
Tumor Necrosis Factor-alpha
Transplants

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation : Analysis of 155 donor-recipient pairs. / Kamei, Hideya; Masuda, Satohiro; Nakamura, Taro; Ishigami, Masatoshi; Fujimoto, Yasuhiro; Ogura, Yasuhiro; Oike, Fumitaka; Takada, Yasutsugu; Hamajima, Nobuyuki.

In: Hepatology International, Vol. 7, No. 3, 01.07.2013, p. 916-922.

Research output: Contribution to journalArticle

Kamei, H, Masuda, S, Nakamura, T, Ishigami, M, Fujimoto, Y, Ogura, Y, Oike, F, Takada, Y & Hamajima, N 2013, 'Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: Analysis of 155 donor-recipient pairs', Hepatology International, vol. 7, no. 3, pp. 916-922. https://doi.org/10.1007/s12072-013-9443-2
Kamei, Hideya ; Masuda, Satohiro ; Nakamura, Taro ; Ishigami, Masatoshi ; Fujimoto, Yasuhiro ; Ogura, Yasuhiro ; Oike, Fumitaka ; Takada, Yasutsugu ; Hamajima, Nobuyuki. / Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation : Analysis of 155 donor-recipient pairs. In: Hepatology International. 2013 ; Vol. 7, No. 3. pp. 916-922.
@article{a751d1be222b4e9395eb5f5e98891fec,
title = "Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: Analysis of 155 donor-recipient pairs",
abstract = "Purpose: Despite improvements in immunosuppressive therapy, acute cellular rejection (ACR) remains an important cause of graft loss in patients undergoing liver transplantation. Recently, associations between cytokine gene polymorphisms in recipients and the occurrence of ACR have been reported. However, most studies did not investigate gene polymorphisms in donors or were limited by the number of cases investigated. Methods: We examined 155 living donor liver transplantation (LDLT) patients treated at Nagoya University or Kyoto University from 2004 to 2009. The following gene polymorphisms in recipients and donors were analyzed: tumor necrosis factor A (TNF-A) T-1031C, interleukin 2 (IL-2) T-330G, IL-10C-819T, IL-13C-1111T, and transforming growth factor B (TGF-B) T29C. Results: Forty-seven recipients (30.3 {\%}) developed early ACR. Of the investigated gene polymorphisms, the IL-13 -1111C/C genotype in recipients was significantly associated with a higher incidence of ACR relative to the other two genotypes (OR = 2.64, 95 {\%} CI 1.19-5.86, p = 0.017), while we showed the lack of association between investigated gene polymorphisms in donors and ACR incidence. Conclusion: The IL-13 -1111C/C genotype in recipients might be a risk factor for ACR in LDLT, and this might contribute to individualized immunosuppression strategies for recipients. On the other hand, the current study showed no associations of cytokine gene polymorphisms in donors with ACR incidence.",
author = "Hideya Kamei and Satohiro Masuda and Taro Nakamura and Masatoshi Ishigami and Yasuhiro Fujimoto and Yasuhiro Ogura and Fumitaka Oike and Yasutsugu Takada and Nobuyuki Hamajima",
year = "2013",
month = "7",
day = "1",
doi = "10.1007/s12072-013-9443-2",
language = "English",
volume = "7",
pages = "916--922",
journal = "Hepatology International",
issn = "1936-0533",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation

T2 - Analysis of 155 donor-recipient pairs

AU - Kamei, Hideya

AU - Masuda, Satohiro

AU - Nakamura, Taro

AU - Ishigami, Masatoshi

AU - Fujimoto, Yasuhiro

AU - Ogura, Yasuhiro

AU - Oike, Fumitaka

AU - Takada, Yasutsugu

AU - Hamajima, Nobuyuki

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Purpose: Despite improvements in immunosuppressive therapy, acute cellular rejection (ACR) remains an important cause of graft loss in patients undergoing liver transplantation. Recently, associations between cytokine gene polymorphisms in recipients and the occurrence of ACR have been reported. However, most studies did not investigate gene polymorphisms in donors or were limited by the number of cases investigated. Methods: We examined 155 living donor liver transplantation (LDLT) patients treated at Nagoya University or Kyoto University from 2004 to 2009. The following gene polymorphisms in recipients and donors were analyzed: tumor necrosis factor A (TNF-A) T-1031C, interleukin 2 (IL-2) T-330G, IL-10C-819T, IL-13C-1111T, and transforming growth factor B (TGF-B) T29C. Results: Forty-seven recipients (30.3 %) developed early ACR. Of the investigated gene polymorphisms, the IL-13 -1111C/C genotype in recipients was significantly associated with a higher incidence of ACR relative to the other two genotypes (OR = 2.64, 95 % CI 1.19-5.86, p = 0.017), while we showed the lack of association between investigated gene polymorphisms in donors and ACR incidence. Conclusion: The IL-13 -1111C/C genotype in recipients might be a risk factor for ACR in LDLT, and this might contribute to individualized immunosuppression strategies for recipients. On the other hand, the current study showed no associations of cytokine gene polymorphisms in donors with ACR incidence.

AB - Purpose: Despite improvements in immunosuppressive therapy, acute cellular rejection (ACR) remains an important cause of graft loss in patients undergoing liver transplantation. Recently, associations between cytokine gene polymorphisms in recipients and the occurrence of ACR have been reported. However, most studies did not investigate gene polymorphisms in donors or were limited by the number of cases investigated. Methods: We examined 155 living donor liver transplantation (LDLT) patients treated at Nagoya University or Kyoto University from 2004 to 2009. The following gene polymorphisms in recipients and donors were analyzed: tumor necrosis factor A (TNF-A) T-1031C, interleukin 2 (IL-2) T-330G, IL-10C-819T, IL-13C-1111T, and transforming growth factor B (TGF-B) T29C. Results: Forty-seven recipients (30.3 %) developed early ACR. Of the investigated gene polymorphisms, the IL-13 -1111C/C genotype in recipients was significantly associated with a higher incidence of ACR relative to the other two genotypes (OR = 2.64, 95 % CI 1.19-5.86, p = 0.017), while we showed the lack of association between investigated gene polymorphisms in donors and ACR incidence. Conclusion: The IL-13 -1111C/C genotype in recipients might be a risk factor for ACR in LDLT, and this might contribute to individualized immunosuppression strategies for recipients. On the other hand, the current study showed no associations of cytokine gene polymorphisms in donors with ACR incidence.

UR - http://www.scopus.com/inward/record.url?scp=84884355051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884355051&partnerID=8YFLogxK

U2 - 10.1007/s12072-013-9443-2

DO - 10.1007/s12072-013-9443-2

M3 - Article

AN - SCOPUS:84884355051

VL - 7

SP - 916

EP - 922

JO - Hepatology International

JF - Hepatology International

SN - 1936-0533

IS - 3

ER -